Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Macular Corneal Dystrophy”

29 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 29 results

Testing effectiveness (Phase 2)Study completedNCT04009668
What this trial is testing

Tumor Necrosis Factor Inhibition in Focal Segmental Glomerulosclerosis and Treatment Resistant Minimal Change Disease

Who this might be right for
FSGSMCDFocal Segmental Glomerulosclerosis+1 more
University of Michigan 7
Not applicableStudy completedNCT01451710
What this trial is testing

The Effectiveness of Enough Steroids as Inducement Therapy in Minimal Change Disease-like IgA Nephropathy

Who this might be right for
IgA Nephropathy
Nanjing University School of Medicine 30
Not applicableStudy completedNCT02423161
What this trial is testing

PIONEER: Intraoperative and Perioperative OCT Study

Who this might be right for
Retinal DetachmentEpiretinal MembraneMacular Hole+1 more
The Cleveland Clinic 750
Early research (Phase 1)Study completedNCT00346853
What this trial is testing

Phase 1 Pilot Study of 4-MP to Treat Stargardt Macular Dystrophy

Who this might be right for
Macular Dystrophy, Corneal
University of Utah 10
Early research (Phase 1)Looking for participantsNCT07267026
What this trial is testing

Evaluate the Safety, Tolerability and PK of SK-09

Who this might be right for
FSGSMCD
Consun Pharmaceutical Group 84
Not applicableLooking for participantsNCT03949972
What this trial is testing

The FOrMe Registry (The German Focal Segmental Glomerulosclerosis and Minimal Change Disease Registry)

Who this might be right for
Glomerulosclerosis, Focal SegmentalMinimal Change DiseaseIdiopathic Nephrotic Syndrome
Prof. Dr. Paul Brinkkoetter 500
Testing effectiveness (Phase 2)Study completedNCT01024036
What this trial is testing

Evaluate the Efficacy and Safety of CNTO328 Plus Best Supportive Care in Multicentric Castleman's Disease

Who this might be right for
Multicentric Castleman's Disease
Janssen Research & Development, LLC 79
Not applicableStudy completedNCT00559234
What this trial is testing

Potential Research Participants for Future Studies of Inherited Eye Diseases

Who this might be right for
CataractGlaucomaRetinitis Pigmentosa+2 more
National Eye Institute (NEI) 400
Not applicableLooking for participantsNCT01209000
What this trial is testing

Nephrotic Syndrome Study Network

Who this might be right for
Minimal Change Disease (MCD)Membranous NephropathyGlomerulosclerosis, Focal Segmental
University of Michigan 1,200
Testing effectiveness (Phase 2)Looking for participantsNCT05003986
What this trial is testing

Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases

Who this might be right for
Focal Segmental GlomerulosclerosisMinimal Change DiseaseImmunoglobulin A Nephropathy+2 more
Travere Therapeutics, Inc. 67
Not applicableLooking for participantsNCT02817997
What this trial is testing

International Registry for Patients With Castleman Disease

Who this might be right for
Castleman DiseaseCastleman's DiseaseGiant Lymph Node Hyperplasia+6 more
University of Pennsylvania 1,000
Testing effectiveness (Phase 2)Study completedNCT04585893
What this trial is testing

Safety and Efficacy of Rituximab for Treatment of Multicentric Castleman Disease in Malawi

Who this might be right for
Multicentric Castleman Disease
UNC Lineberger Comprehensive Cancer Center 15
Not applicableStudy completedNCT01568177
What this trial is testing

Cardiac Autonomic Function in Women with Microvascular Coronary Dysfunction

Who this might be right for
Microvascular Coronary Dysfunction
Cedars-Sinai Medical Center 105
Not applicableLooking for participantsNCT04129021
What this trial is testing

High Resolution, High-speed Multimodal Ophthalmic Imaging

Who this might be right for
Retinitis PigmentosaMaculopathy, Age RelatedMacular Dystrophy+12 more
Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts 1,200
Not applicableLooking for participantsNCT05650619
What this trial is testing

Recurrence Post-transplant Observational Study in Focal Segmental Glomerulosclerosis and Minimal Change Disease

Who this might be right for
Focal Segmental GlomerulosclerosisMinimal Change DiseaseFSGS+1 more
University of Michigan 300
Not applicableLooking for participantsNCT06491615
What this trial is testing

National Ophthalmic Genotyping and Phenotyping Network (eyeGENE (Registered Trademark)), Stage 3 - Expansion of DNA and Data Repositories for Rare Inherited Ophthalmic Diseases

Who this might be right for
Inherited Ophthalmic DiseasesHypopigmentation DisorderCorneal Dystrophy+4 more
National Eye Institute (NEI) 1,000
Not applicableLooking for participantsNCT04571658
What this trial is testing

NEPTUNE Match Study

Who this might be right for
Nephrotic Syndrome in ChildrenFocal Segmental GlomerulosclerosisMinimal Change Disease+6 more
University of Michigan 375
Testing effectiveness (Phase 2)Active Not RecruitingNCT03933904
What this trial is testing

Sirolimus in Previously Treated Idiopathic Multicentric Castleman Disease

Who this might be right for
Castleman DiseaseCastleman's Disease, Multicentric
University of Pennsylvania 7
Not applicableStudy completedNCT02853968
What this trial is testing

Unlock the Cell: Castleman's Disease Flow Cytometry Study

Who this might be right for
Castleman DiseaseAngiofollicular Lymphoid HyperplasiaGLNH+4 more
University of Pennsylvania 130
Not applicableStudy completedNCT07702981
What this trial is testing

Immunophenotyping Profiling in Patients With Primary Nephrotic Syndrome

Who this might be right for
Membranous NephropathyMinimal Change Disease (MCD)Focal Segmental Glomerulosclerosis (FSGS)
University Hospital, Ioannina 40
Next Page